Target intelligence / Profile preview

RNA, U6 small nuclear 1266, pseudogene (RNU6-1266P)

Target
RNU6-1266P
Molecular classification
Pseudogene, Small nuclear RNA (snRNA)-derived pseudogene, Non-coding RNA pseudogene
01

Overview

RNU6-1266P (RNA, U6 small nuclear 1266, pseudogene) is a non-coding RNA pseudogene derived from the gene encoding U6 small nuclear RNA, which is a highly conserved snRNA essential for mRNA splicing in the spliceosome[2][3][5]. As a pseudogene, RNU6-1266P does not produce functional U6 snRNA and is not directly involved in the catalytic splicing reaction[2][5]. Pseudogenes like RNU6-1266P are considered non-functional remnants of gene evolution, though some pseudogenes can act through RNA-based regulatory mechanisms (such as generating non-coding RNAs that interact with microRNAs or mRNAs), but no specific evidence exists for RNU6-1266P performing such a role[4][6]. It is not considered a therapeutic target, nor does it have a characterized role as a biomarker or disease gene. The presence of many U6 snRNA pseudogenes in the human genome underscores the evolutionary importance of the U6 snRNA, but these pseudogenes themselves are typically biologically inert[1][3].

Other names
RNU6-1266PRNA, U6 small nuclear 1266, pseudogene
02

Biological functions

May contribute RNA species functioning as antisense RNAs, small interfering RNAs (siRNAs), or competing endogenous RNAs (ceRNAs) in rare cases for some pseudogenes[4][6]No direct biological function established for RNU6-1266P itself; functional U6 snRNA is involved in pre-mRNA splicing, but this entry is a pseudogene[1][3]
03

Disease associations

OtherPseudogenes can be aberrantly expressed and linked to disease via RNA-based regulatory mechanisms, but specific disease relevance for RNU6-1266P is not established[4][6]

Beyond the preview

Go deeper on RNA, U6 small nuclear 1266, pseudogene (RNU6-1266P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1266, pseudogene (RNU6-1266P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call